CN110024932A - A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora - Google Patents
A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora Download PDFInfo
- Publication number
- CN110024932A CN110024932A CN201910354913.6A CN201910354913A CN110024932A CN 110024932 A CN110024932 A CN 110024932A CN 201910354913 A CN201910354913 A CN 201910354913A CN 110024932 A CN110024932 A CN 110024932A
- Authority
- CN
- China
- Prior art keywords
- solid beverage
- parts
- beverage formula
- preparation
- black fungus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007787 solid Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 241000233866 Fungi Species 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 title claims abstract description 20
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 18
- 238000009472 formulation Methods 0.000 title description 4
- 235000013361 beverage Nutrition 0.000 claims abstract description 43
- 239000006041 probiotic Substances 0.000 claims abstract description 24
- 235000018291 probiotics Nutrition 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 23
- 235000013305 food Nutrition 0.000 claims abstract description 20
- 230000000529 probiotic effect Effects 0.000 claims abstract description 16
- 229920001202 Inulin Polymers 0.000 claims abstract description 15
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 15
- 229940029339 inulin Drugs 0.000 claims abstract description 15
- 241000219051 Fagopyrum Species 0.000 claims abstract description 14
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 14
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 13
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 4
- 229940100688 oral solution Drugs 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000020985 whole grains Nutrition 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- -1 hydroxy-propyl Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019722 synbiotics Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 229940126572 wide-spectrum antibiotic Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Abstract
The present invention provides a kind of solid beverage formula, it further includes buckwheat oligopeptide that formula, which contains black fungus extract, oligofructose, inulin, probiotic powder,.It additionally provides and a kind of preparation method for losing weight, improve diarrhea, adjusting flora solid beverage formula is provided.A kind of solid beverage formula is further provided in preparation weight-reducing or improves diarrhea or adjusts the application in flora food or Special food or drug.
Description
Technical field
The present invention relates to food, Special food, medicine field, in particular to one kind for lose weight, improve diarrhea,
Adjust the black fungus extract solid drink formula and preparation method thereof of flora.
Background technique
Adult gastrointestinal tract mucous surface area is body and the maximum device that external environment interacts up to 300 square metres
Official.A large amount of fungal component is inhabited in human gastrointestinal tract, type is more than 1000 kinds, and total weight is close to 2 kilograms;Total number of bacteria reaches
100000000000000, about the 10 of human body cell summation times;Its gene encoded is about 150 times of human genome, therefore it is regarded
It is another " hiding organ " for human body, carry human body " the second gene ".
According to the relationship with host, enteric microorganism can be divided into probiotics, conditioned pathogen and pathogenic bacteria.Probiotics is
Referring to improves host's microecological balance and plays beneficial effect, reach improve that host health is horizontal and the active bacteria formulation of health status and
Its metabolite.Beneficial bacteria of intestinal tract is mainly reflected in the metabolism for participating in nutriment to human body effect, biological barrier effect, is immunized
Effect etc..
Under normal circumstances, the intestinal microecology of Healthy People maintains a relatively stable state, but human enteric bacteria group structure is simultaneously
It is not constant between, but is in dynamic equilibrium.Age, diet, gender, environment, health status and long-term a large amount of uses are wide
Spectrum antibiotic can impact intestinal microflora, so that human gastrointestinal tract be made to be among risk.Studies have shown that fertile
Fat, acute and chronic diarrhea, constipation, indigestion, chronic hepatic diseases, diabetes, atherosclerosis and mental disease etc. all with
Intestinal flora has substantial connection, how by nutritional intervention adjusting intestinal microflora, micro-ecological environment, to reduce this kind of disease
The disease incidence of disease, oneself becomes the important topic studied in the art.
Although there is the product of probiotics, prebiotics or synbiotic now, it is most of be by supplement merely it is single or
Several floras or simple prebiotic-supplemented or the simple combination of probiotics and prebiotics, without type needed for growth of probiotics
The supplement of complete system trophism object, cause prebiotics and probiotics to be absorbed and utilized degree lower, by improving supplement merely
Prebiotics and probiotics type and quantity can not build the long-term health condition of enteron aisle, palliative, ask gastrointestinal health
Topic cannot be well solved.
Summary of the invention
The first aspect of the present invention is designed to provide a kind of solid beverage formula.
A kind of preparation method for being designed to provide solid beverage of the second aspect of the present invention.
The third aspect of the present invention be designed to provide it is a kind of weight-reducing, improve diarrhea, adjustment flora matched with solid beverage
Side.
The fourth aspect of the present invention be designed to provide it is a kind of weight-reducing, improve diarrhea, adjustment flora matched with solid beverage
The preparation method of side.
The fifth aspect of the present invention has been designed to provide a kind of solid beverage formula in preparation weight-reducing or improves diarrhea
Or the application in adjustment flora food or Special food or drug.
In order to realize above-mentioned purpose of the invention, the following technical scheme is adopted:
A kind of solid beverage formula contains black fungus extract, oligofructose, inulin, probiotic powder.
Further, which further includes buckwheat oligopeptide.
Each material of recipe quantity is weighed, routinely preparation method makes solid beverage.
Powder, tablet, capsule, granule or oral solution can be made in solid beverage formula.
The preparation method of solid beverage formula is produced using dry process, comprising the following steps: crush, sieving, be pre-mixed,
Total mix, packing, packaging.
Above-mentioned solid beverage formula is in preparation weight-reducing or improves in diarrhea or adjustment flora food or Special food or drug
Application.
Compared with prior art, present disclosure the utility model has the advantages that
Inulin, oligofructose, these sweeteners substitute sucrose for general population, especially diabetic, have weight
Want meaning.For fat type 2 diabetic patient, loss of weight can improve insulin resistance, to help to control blood glucose.Body
The every reduction 1kg of weight, blood pressure decline about 1mmHg, and the triglycerides in blood lipid declines about 2mmol/L, blood glucose decline about 10%.
Volume expansion after the water suction of black fungus extract etc. contained by product becomes the sticking dietary fiber of tool, can subtract
Slow food passing through from stomach to small intestine delays digestion and absorption nutriment so that fatty acid is existed due to reducing the absorption of monosaccharide
Synthesis decline in vivo, to achieve the effect that weight-reducing.A kind of satiety is generated after product is edible, plays control to a certain extent
The effect of diet.Raw material in product has the effect of improving diarrhea, makes partially not being digested the nutriment of absorption with excrement
Ease constipation weight-reducing is played the role of in discharge.
Product of the present invention weight reducing moulding, generates satiety, the fine figure of shape healthy;Improve diarrhea, improves constipation, clearly
Manage the toxin of enteron aisle and the accumulation of body median year.
The solid beverage that present disclosure provides, black fungus extract, oligofructose, chrysanthemum than independent identical weight number
Powder, probiotic powder, buckwheat oligopeptide, better effect.Multicomponent plays synergistic weight-reducing jointly, improves diarrhea and immune tune
Section effect.
Specific embodiment
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will
Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the invention.It is not specified in embodiment specific
Condition person carries out according to conventional conditions or manufacturer's recommended conditions.Reagents or instruments used without specified manufacturer is
The conventional products that can be obtained by commercially available purchase, lactobacillus plantarum, lactobacillus acidophilus, the bacterium that bifidobacterium lactis is market purchasing
Powder raw material (10~300,000,000,000 cfu/g).
Present embodiment provides a kind of solid beverage formula, contains black fungus extract, oligofructose, inulin, probiotics
Powder.
Further, which further includes buckwheat oligopeptide.
Further, the solid beverage formula contains 200~500 parts of black fungus extract, low according to parts by weight
60~200 parts of Fructooligosaccharides, 30~80 parts of inulin, 10~90 parts of probiotic powder, 30~80 parts of buckwheat oligopeptide.
Preferably, the solid beverage formula contains 300 parts of black fungus extract, oligofructose 100 according to parts by weight
Part, 50 parts of inulin, 50 parts of probiotic powder, 50 parts of buckwheat oligopeptide.
The preparation method of solid beverage, routinely preparation method makes.Can weigh by formula rate can be by matching
Square ratio weighs the materials such as a certain amount of black fungus extract and is uniformly mixed, and ethanol solution makees wetting agent, continues stirring 15 minutes,
So that material is reached the state of " that holds is agglomerating, and touching dissipates ", is pelletized with 16 mesh screens, (temperature is kept for 60 DEG C, and the time is for drying
1.5~2 hours), after drying with 16 mesh screen whole grains to get.
The preparation method of the solid beverage formula, comprising the following steps:
Raw material is weighed by weight;80 mesh crush, 50 mesh sieves, and premixing is mixed by equal increments method, take a small amount of
The big component of the amount of component and equivalent, while being placed in mixing machinery and being uniformly mixed, the amount for adding same mixture equivalent are big
Component is uniformly mixed, and so a times amount is increased up until adding the big component of whole amount.Incorporation time 25~35 minutes, revolving speed was
8~10 revs/min, total mix is mixed using three-dimensional motion mixer, and incorporation time 25~35 minutes, solid beverage formula is made.
Present embodiment also provides a kind of preparation, which includes above-mentioned solid beverage formula and food, special food
Oral preparation can be made in product or pharmaceutically acceptable carrier or auxiliary material.
Said preparation can be powder, tablet, capsule, granule or oral solution.
Herein, term " food, Special food or pharmaceutically acceptable " refers to the chemical combination when compound is to human administration
Object is physiologically acceptable, and the allergic reactions such as gastrointestinal disturbance, dizziness or anaphylactoid similar to these will not occur
Systemic anaphylaxis.
In the present invention, " food, Special food or pharmaceutically acceptable carrier or auxiliary material " includes but is not limited to: bonding
Agent (such as microcrystalline cellulose, alginates, gelatin and polyvinylpyrrolidone), filler (such as starch, sucrose, glucose and anhydrous
Lactic acid), disintegrating agent (such as cross-linked pvp, crosslinked carboxymethyl fecula sodium, croscarmellose sodium and low substituted hydroxy-propyl fiber
Element), lubricant (magnesium stearate, aluminum stearate, talcum, polyethylene glycol, sodium benzoate), wetting agent (such as glycerol), surface-active
Agent (such as hexadecanol) and sorbefacient, corrigent, sweetener, diluent, coating agent.
Present embodiment also provides a kind of above-mentioned solid beverage formula in preparing diet food or Special food or drug
Application.
Feature of the invention is described in further detail with reference to embodiments:
Embodiment 1
The present embodiment provides a kind of solid beverage formulas comprising:
Weigh 300 grams of black fungus extract, 300 grams of oligofructose, 50 grams of inulin, probiotic powder (lactobacillus acidophilus) 50
Gram, 120 mesh crush respectively, 100 mesh sieves, mix 30 minutes, and ethanol solution makees wetting agent, continue stirring 15 minutes, make object
Material reaches the state of " that holds is agglomerating, and touching dissipates ", is pelletized with 16 mesh screens, and (temperature is kept for 60 DEG C, and the time is 1.5 small for drying
When), after drying with 16 mesh screen whole grains to get.
Embodiment 2
The present embodiment provides a kind of solid beverage formulas comprising:
200 grams of black fungus extract, 200 grams of oligofructose, 30 grams of inulin, probiotic powder 90 grams of (lactobacillus plantarum), buckwheats
30 grams of wheat oligopeptide, 120 mesh crush respectively, 100 mesh sieves, mix 30 minutes, ethanol solution makees wetting agent, continues stirring 15
Minute makes material reach the state of " that holds is agglomerating, and touching dissipates ", is pelletized with 16 mesh screens, drying (60 DEG C of temperature holding, when
Between be 2 hours), after drying with 16 mesh screen whole grains to get.
Embodiment 3
The present embodiment provides a kind of solid beverage formulas comprising:
500 parts of black fungus extract, 60 parts of oligofructose, 80 parts of inulin, probiotic powder (lactobacillus plantarum: newborn bifid bar
Bacterium=3:5) 30 parts, 80 parts of buckwheat oligopeptide, 120 mesh crush respectively, 100 mesh sieves, mix 30 minutes, ethanol solution is made wet
Moisten agent, continue stirring 15 minutes, so that material is reached the state of " that holds is agglomerating, and touching dissipates ", pelletized with 16 mesh screens, drying
(temperature keep 60 DEG C, the time be 1.5 hours), after drying with 16 mesh screen whole grains to get.
Embodiment 4
(lactobacillus acidophilus: cream is double for 300 grams of black fungus extract, 80 grams of oligofructose, 50 grams of inulin, 30 grams of probiotic powder
Discrimination bacillus=2:5), 30 grams of buckwheat oligopeptide, respectively 120 mesh crush, 100 mesh sieves, mix 30 minutes, ethanol solution is made wet
Moisten agent, continue stirring 15 minutes, so that material is reached the state of " that holds is agglomerating, and touching dissipates ", pelletized with 16 mesh screens, drying
(temperature keep 60 DEG C, the time be 2 hours), after drying with 16 mesh screen whole grains to get.
Embodiment 5
300 grams of black fungus extract, 100 grams of oligofructose, 50 grams of inulin, probiotic powder (lactobacillus plantarum: acidophilus cream bar
Bacterium: bifidobacterium lactis=3:2:5) 10 grams, 50 grams of buckwheat oligopeptide, 120 mesh crush respectively, and 100 mesh sieves are placed in mixing machine
Incorporation time 30 minutes, revolving speed was 10 revs/min, and total mix is mixed using three-dimensional motion mixer, incorporation time 30 minutes, was made solid
Body drink formula.
Embodiment 6
300 grams of black fungus extract, 100 grams of oligofructose, 50 grams of inulin, probiotic powder (lactobacillus plantarum: acidophilus cream bar
Bacterium 3:2) 50 grams, 50 grams of buckwheat oligopeptide, 120 mesh crush respectively, and 100 mesh sieves are placed in mixing machine incorporation time 30 minutes,
Revolving speed is 9 revs/min, and total mix is mixed using three-dimensional motion mixer, and incorporation time 30 minutes, solid beverage formula is made.
Embodiment 7
The present embodiment provides a kind of tablet, the preparation method of the tablet includes:
Appropriate amount of starch, dextrin is added in 6 solid beverage formula of above-described embodiment, is uniformly mixed, and particle is made, and tabletting is wrapped thin
Film clothing is to get tablet.
Embodiment 8
The present embodiment provides a kind of capsule, the preparation method of the capsule includes:
Appropriate amount of starch, dextrin is added in 6 solid beverage formula of above-described embodiment, mixes, and particle is made, and is packed into hard capsule, i.e.,
Obtain capsule.
Embodiment 9
The present embodiment provides a kind of granule, the preparation method of the granule includes:
Appropriate amount of starch, dextrin is added in 6 solid beverage formula of above-described embodiment, mixes, wet granulation, whole grain after drying, packet
Dress is to get granule.
Experimental example 1
Select rat 70,180-220 grams of weight.It is randomly divided into 7 groups, every group 10, respectively Normal group, specific
Embodiment 1-6 group.
7 groups of rats change feeding high lipid food, and (formula is 78.8% basal feed, 1% cholesterol, 10% yolk powder, 10%
Lard, 0.2% cholate), it feeds 7 days.
After 7 days, Normal group feeds normal diet;Specific embodiment 1-6 group feeds above-mentioned specific embodiment 1-6 group
Formula is fed 30 days.
After 30 days, fasting 12h after last feeding, after weighing, rat plucks eyeball and takes blood, serum is separated, with kit side
Method surveys TG, TC.
Table 1 to rat weight influence (N=10)
Group | Weight |
Normal group | 208.6±19.9 |
Example 1 group | 203.8±20.2 |
2 groups of embodiment | 205.6±19.1 |
3 groups of embodiment | 201.8±18.5 |
4 groups of embodiment | 200.1±19.3 |
5 groups of embodiment | 196.2±17.6 |
6 groups of embodiment | 199.5±18.5 |
As can be seen from Table 1, specific embodiment 1-6 group is compared with Normal group, and weight has notable difference.
Table 2 to rat total cholesterol (TC) and triglycerides (TG) influence (N=10)
Group | Total cholesterol (mmol/L) | Triglycerides (mmol/L) |
Normal group | 2.39±0.29 | 1.56±0.50 |
Example 1 group | 2.17±0.28 | 1.38±0.38 |
2 groups of embodiment | 2.15±0.23 | 1.35±0.35 |
3 groups of embodiment | 2.11±0.25 | 1.23±0.33 |
4 groups of embodiment | 1.95±0.22 | 1.26±0.29 |
5 groups of embodiment | 1.86±0.23 | 1.13±0.23 |
6 groups of embodiment | 1.96±0.21 | 1.16±0.25 |
As shown in Table 2, Examples 1 to 6 group compared with the control group, the total cholesterol and glycerol three of Examples 1 to 6 group rat
Ester is substantially reduced.
Experimental example 2 improves diarrhea situation observation experiment
One, the general information of experimental subjects: using 22 habitual diarrhea persons for the treatment of, wherein male 16, female 6;Age
The maximum 61 years old, youngest person 25 years old.
Two, treatment method:
Usage and dosage: three times a day, 10 grams every time, warm water takes 9 sample of the embodiment of the present invention.
The course for the treatment of: a month as a course for the treatment of, treats 3 courses for the treatment of altogether.
Three, the standard of curative effect evaluation
Recovery from illness: sign and symptom improve completely, and stool is completely normal, in high spirits.
Effective: sign and symptom significantly improve, and defecate normal, and spirit is very well.
Effective: sign and symptom have change, and stool significantly improves.
Invalid: sign is curved without changing, and sumptom is the same as before.
Five, result:
It treats within 3 months, wherein recovery from illness 8, effective 7, effective 5, invalid 2, total effective rate is up to 91%.As a result table
Bright, the present invention has remarkable result to habitual diarrhea person.
Although illustrate and describing the present invention with specific embodiment, it will be appreciated that without departing substantially from of the invention
Many other change and modification can be made in the case where spirit and scope.It is, therefore, intended that in the following claims
Including belonging to all such changes and modifications in the scope of the invention.
Claims (10)
1. a kind of solid beverage formula, which is characterized in that the solid beverage formula contain black fungus extract, oligofructose,
Inulin, probiotic powder.
2. solid beverage formula according to claim 1, which is characterized in that the solid beverage formula further includes that buckwheat is low
Poly- peptide.
3. solid beverage formula according to claim 2, which is characterized in that according to parts by weight, the black fungus extracts
200~500 parts of object, 60~200 parts of oligofructose, 30~80 parts of inulin, 10~90 parts of probiotic powder, buckwheat oligopeptide 30~80
Part.
4. solid beverage formula according to claim 2, which is characterized in that according to parts by weight, the black fungus extracts
300 parts of object, 100 parts of oligofructose, 50 parts of inulin, 50 parts of probiotic powder, 50 parts of buckwheat oligopeptide.
5. solid beverage formula according to claim 5, which is characterized in that the probiotic powder be lactobacillus plantarum and/
Or lactobacillus acidophilus and/or bifidobacterium lactis.
6. solid beverage formula according to claim 5, which is characterized in that the probiotic powder is lactobacillus plantarum: thermophilic
Lactobacillus lactis: bifidobacterium lactis=3:2:5.
7. a kind of preparation method of solid beverage as claimed in claim 6, which is characterized in that each material of recipe quantity is weighed, by normal
The production of regulation Preparation Method.
8. solid beverage formula according to claims 1 to 7, which is characterized in that the solid beverage formula be made powder,
Tablet, capsule, granule or oral solution.
9. a kind of preparation method of solid beverage formulas described in any item according to claim 1~7, which is characterized in that use
Dry process production, comprising the following steps: crushing, sieving, premixing, total mix, packing, packaging.
10. one kind solid beverage formula as described in any one of claim 1~7 in preparation weight-reducing or improves diarrhea or adjustment flora
Application in food or Special food or drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910354913.6A CN110024932A (en) | 2019-04-29 | 2019-04-29 | A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910354913.6A CN110024932A (en) | 2019-04-29 | 2019-04-29 | A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110024932A true CN110024932A (en) | 2019-07-19 |
Family
ID=67240687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910354913.6A Pending CN110024932A (en) | 2019-04-29 | 2019-04-29 | A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110024932A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111084317A (en) * | 2020-03-04 | 2020-05-01 | 赵保国 | Health-care solid beverage and preparation method thereof |
CN111657351A (en) * | 2020-05-21 | 2020-09-15 | 长沙重链抗体研究院 | Solid beverage for conditioning autism and preparation method and application thereof |
CN113016950A (en) * | 2021-04-20 | 2021-06-25 | 哈尔滨求真生物科技有限公司 | Series products prepared from bagasse, preparation method and comprehensive utilization method of bagasse |
CN115671132A (en) * | 2020-06-01 | 2023-02-03 | 山东新时代药业有限公司 | Composition of probiotics and prebiotics and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104544086A (en) * | 2015-01-23 | 2015-04-29 | 绍兴上虞宏晟技术转让服务有限公司 | Health food capable of improving intestinal flora and preparation method of health food |
CN106954847A (en) * | 2017-03-30 | 2017-07-18 | 广州能靓生物技术有限公司 | Ferment probiotic composition with function of relaxing bowel, using and process preparation |
CN108523135A (en) * | 2018-03-27 | 2018-09-14 | 苏州绿叶日用品有限公司 | A kind of composition and its application containing profitable probliotics |
CN109549052A (en) * | 2019-01-08 | 2019-04-02 | 黑龙江省科学院微生物研究所 | A kind of solid beverage and weight-reducing meal replacement powder formula and preparation method thereof |
CN109602018A (en) * | 2018-12-13 | 2019-04-12 | 北京东方倍力营养科技有限公司 | A kind of compound probiotic with quick improvement gastrointestinal function |
-
2019
- 2019-04-29 CN CN201910354913.6A patent/CN110024932A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104544086A (en) * | 2015-01-23 | 2015-04-29 | 绍兴上虞宏晟技术转让服务有限公司 | Health food capable of improving intestinal flora and preparation method of health food |
CN106954847A (en) * | 2017-03-30 | 2017-07-18 | 广州能靓生物技术有限公司 | Ferment probiotic composition with function of relaxing bowel, using and process preparation |
CN108523135A (en) * | 2018-03-27 | 2018-09-14 | 苏州绿叶日用品有限公司 | A kind of composition and its application containing profitable probliotics |
CN109602018A (en) * | 2018-12-13 | 2019-04-12 | 北京东方倍力营养科技有限公司 | A kind of compound probiotic with quick improvement gastrointestinal function |
CN109549052A (en) * | 2019-01-08 | 2019-04-02 | 黑龙江省科学院微生物研究所 | A kind of solid beverage and weight-reducing meal replacement powder formula and preparation method thereof |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111084317A (en) * | 2020-03-04 | 2020-05-01 | 赵保国 | Health-care solid beverage and preparation method thereof |
CN111657351A (en) * | 2020-05-21 | 2020-09-15 | 长沙重链抗体研究院 | Solid beverage for conditioning autism and preparation method and application thereof |
CN115671132A (en) * | 2020-06-01 | 2023-02-03 | 山东新时代药业有限公司 | Composition of probiotics and prebiotics and application thereof |
CN115671132B (en) * | 2020-06-01 | 2024-03-15 | 山东新时代药业有限公司 | Composition of probiotics and prebiotics and application thereof |
CN113016950A (en) * | 2021-04-20 | 2021-06-25 | 哈尔滨求真生物科技有限公司 | Series products prepared from bagasse, preparation method and comprehensive utilization method of bagasse |
CN113016950B (en) * | 2021-04-20 | 2024-03-05 | 中粮崇左糖业有限公司 | Series products prepared from bagasse, preparation method and bagasse comprehensive utilization method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110024932A (en) | A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora | |
JP6271571B2 (en) | Composition for maintaining intestinal microbiota equilibrium, process for producing the composition, and use of the composition | |
CN104642870B (en) | A kind of prebiotic compositions | |
KR20150118084A (en) | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions | |
CN112716982B (en) | Lactic acid bacteria-containing composition and use thereof | |
NZ501957A (en) | Health supplement containing a bulk forming material, cholesterol reducer and a fatty acid promoter | |
JP2000175615A (en) | Symbiotic functional food | |
AU2005294369A1 (en) | Synbiotics | |
CN105249480A (en) | Chewable tablet with dietary fiber and bifidobacteria and preparing method thereof | |
CN111000246A (en) | Probiotic dietary fiber composition for assisting in reducing triglyceride, application thereof and health-care product | |
CN111528479A (en) | Probiotics and prebiotics composition for relieving atopic dermatitis function and application | |
CN106723087A (en) | A kind of tablet containing kelp dietary fiber and preparation method thereof | |
CN105982009A (en) | Composition for regulating human body intestinal micro-ecology | |
CN114376235B (en) | Weight-losing probiotics and prebiotic composition for controlling body fat and preparation method thereof | |
CN114145459A (en) | Lactic acid bacteria-containing composition, preparation method and application thereof | |
CN113750113B (en) | Composition of probiotics and prebiotics and application thereof | |
ES2357408T3 (en) | SYMBOLIC COMPOSITION AND ITS MANUFACTURING PROCEDURE. | |
CN114259050A (en) | Beverage for improving intestinal function and preparation method thereof | |
CN112931883A (en) | Prebiotic composition and preparation method and application thereof | |
CN107752015A (en) | The composite nutrient food that a kind of all-digestive tract improves | |
KR20110116344A (en) | Composition for improving bowel function and relieving constipation containing dietary fiber, oligosaccharide and bacillus coagulans | |
CN101297820A (en) | Streptococcus faecium function signal molecule formulation and product thereof for reducing fat and slimming | |
US10448661B2 (en) | Dry food composition | |
CN107950864A (en) | A kind of symphysis unit paddy vegetable meal replacement powder and its preparation method and application | |
WO2014134830A1 (en) | Edible composition, food product comprising same, and preparation method for the food product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 150000 room 401-168, floor 4, building 13, Harbin Songbei (Shenzhen Longgang) science and Technology Innovation Industrial Park, No. 3043, Zhigu Second Street, Songbei District, Harbin City, Heilongjiang Province Applicant after: Harbin Qiuzhen Biotechnology Co.,Ltd. Address before: 150 000 Unit 1, Unit 3, Unit 1, Ansong Street, Daoli District, Harbin City, Heilongjiang Province Applicant before: Harbin Qiuzhen Biotechnology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190719 |
|
RJ01 | Rejection of invention patent application after publication |